XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Restatement of previously issued condensed interim consolidated financial statements - Statements Of Cash Flows (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jan. 31, 2019
Jan. 31, 2018
Jan. 31, 2019
Jan. 31, 2018
Jul. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Income (Loss) $ (12,524,584) $ (9,829,578) $ 5,397,996 $ 17,696,928 $ 35,948,698
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     378,200 2,022  
Issuance of stock options as compensation     924,845  
Changes in fair value of contingent purchase consideration     (15,147,591) (18,776,629)  
Change in fair value of derivative liabilities - convertible notes     (177,844)  
Change in fair value of derivative liabilities - warrants     35,119  
Impairment of long-lived assets 99,519 99,519  
Changes in operating assets and liabilities:          
Accounts receivable     686,889 (175)  
Inventory     385,987 (2,011)  
Accounts payable and accrued expenses     3,296,630 211,670  
Accrued interest on notes receivable     (18,288)  
Other current assets     2,936 (205,097)  
Other assets, net     (10,997)  
Other current liabilities     4,620  
Other noncurrent liabilities     171,562  
Net Cash Used in Operating Activities     (3,970,417) (1,073,292)  
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment     (26,671) (5,385)  
Purchase of intangible assets     (26,488)  
Disposal of propoerty and equipment        
Issuance of note payable        
Cash received in acquisition of a business     1,722,814  
Net cash used in investing activities     1,669,655 (5,385)  
CASH FLOWS FROM FINANCING ACTIVITIES          
Loan proceeds from related party     (3,305) 126,101  
Payment of notes payable     (28,640)  
Proceeds from note payable     3,524,460  
Investment in subsidiary by noncontrolling interest     133,679 125,376 327,593
Net Cash Provided by Financing Activities     3,626,194 251,477  
Effects of currency translation on cash and cash equivalents     2,024 (3,898)  
Net increase (decrease) in Cash and Cash Equivalents     1,327,456 (831,098)  
Cash and Cash Equivalents, beginning of period     1,046,365 2,879,165 $ 2,879,165
Cash and Cash Equivalents, end of period 2,373,821 $ 2,048,067 2,373,821 2,048,067  
Supplemental Disclosure of Cash Flow Information          
Acquisition of Veneto assets & liabilities - First Closing     (13,947,462)  
Acquisition of Veneto assets & liabilities - Second Closing     (19,948,909)  
Acquisition of Regentys assets & liabilities     (337,538)  
Acquisition of Olaregen assets & liabilities     212,355  
Extinguishment of HDS debt     (14,056,109)  
Note payable issued for acquisition of a business     35,000,000 320,000  
Discounts on note payable and convertible debt     165,833  
Market value of convertible notes     (2,110,000)    
Derivative liability - convertible notes     2,530,983  
Derivative liability - convertible warrants     157,552  
Conversion of series H convertible preferred stock to common stock     25,200  
Conversion of series I convertible preferred stock to common stock     6,631  
As Previously Reported [Member]          
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Income (Loss)     5,565,100    
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     73,034    
Issuance of stock options as compensation     924,845    
Changes in fair value of contingent purchase consideration     (15,147,591)    
Change in fair value of derivative liabilities - convertible notes     202,500    
Change in fair value of derivative liabilities - warrants        
Impairment of long-lived assets        
Changes in operating assets and liabilities:          
Accounts receivable     516,822    
Inventory     389,924    
Accounts payable and accrued expenses     3,285,385    
Accrued interest on notes receivable     (18,288)    
Other current assets     9,094    
Other assets, net     (10,997)    
Other current liabilities        
Other noncurrent liabilities        
Net Cash Used in Operating Activities     (4,210,172)    
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment     (10,070)    
Purchase of intangible assets        
Disposal of propoerty and equipment     (5,393)    
Issuance of note payable     13,986    
Cash received in acquisition of a business     1,722,814    
Net cash used in investing activities     1,721,337    
CASH FLOWS FROM FINANCING ACTIVITIES          
Loan proceeds from related party     (3,305)    
Payment of notes payable     (28,011)    
Proceeds from note payable     3,524,460    
Investment in subsidiary by noncontrolling interest     133,679    
Net Cash Provided by Financing Activities     3,626,823    
Effects of currency translation on cash and cash equivalents     2,024    
Net increase (decrease) in Cash and Cash Equivalents     1,140,012    
Cash and Cash Equivalents, beginning of period     1,046,365    
Cash and Cash Equivalents, end of period 2,186,377   2,186,377    
Supplemental Disclosure of Cash Flow Information          
Acquisition of Veneto assets & liabilities - First Closing        
Acquisition of Veneto assets & liabilities - Second Closing        
Acquisition of Regentys assets & liabilities        
Acquisition of Olaregen assets & liabilities        
Extinguishment of HDS debt        
Note payable issued for acquisition of a business        
Discounts on note payable and convertible debt        
Market value of convertible notes        
Derivative liability - convertible notes        
Derivative liability - convertible warrants        
Conversion of series H convertible preferred stock to common stock        
Conversion of series I convertible preferred stock to common stock        
Adjusted [Member]          
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Income (Loss)     (167,104)    
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     305,166    
Issuance of stock options as compensation        
Changes in fair value of contingent purchase consideration        
Change in fair value of derivative liabilities - convertible notes     (380,344)    
Change in fair value of derivative liabilities - warrants     35,119    
Impairment of long-lived assets     99,519    
Changes in operating assets and liabilities:          
Accounts receivable     170,067    
Inventory     (3,937)    
Accounts payable and accrued expenses     11,245    
Accrued interest on notes receivable        
Other current assets     (6,158)    
Other assets, net        
Other current liabilities     4,620    
Other noncurrent liabilities     171,562    
Net Cash Used in Operating Activities     239,755    
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment     (16,601)    
Purchase of intangible assets     (26,488)    
Disposal of propoerty and equipment     5,393    
Issuance of note payable     (13,986)    
Cash received in acquisition of a business        
Net cash used in investing activities     (51,682)    
CASH FLOWS FROM FINANCING ACTIVITIES          
Loan proceeds from related party        
Payment of notes payable     (629)    
Proceeds from note payable        
Investment in subsidiary by noncontrolling interest        
Net Cash Provided by Financing Activities     (629)    
Effects of currency translation on cash and cash equivalents        
Net increase (decrease) in Cash and Cash Equivalents     187,444    
Cash and Cash Equivalents, end of period $ 187,444   187,444    
Supplemental Disclosure of Cash Flow Information          
Acquisition of Veneto assets & liabilities - First Closing     (13,947,462)    
Acquisition of Veneto assets & liabilities - Second Closing     (19,948,909)    
Acquisition of Regentys assets & liabilities     (337,538)    
Acquisition of Olaregen assets & liabilities     212,355    
Extinguishment of HDS debt     (14,056,109)    
Note payable issued for acquisition of a business     35,000,000    
Discounts on note payable and convertible debt     165,833    
Market value of convertible notes     (2,110,000)    
Derivative liability - convertible notes     2,530,983    
Derivative liability - convertible warrants     157,552    
Conversion of series H convertible preferred stock to common stock     25,200    
Conversion of series I convertible preferred stock to common stock     $ 6,631